Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Microneedle-delivered polyglutamate effectively and safely improves hair growth in androgenetic alopecia.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Prostaglandin F2alpha and related compounds can increase hair growth and darken hair in mice.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

PRP injections significantly improve hair regrowth in alopecia areata.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Alpha-blocker therapy may not be needed long-term when combined with finasteride for BPH.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Six African American women experienced hair loss after switching to a new HIV medication.

CS12192 effectively treats alopecia areata with better safety than current options.

A blood pressure drug, diltiazem, may also help treat influenza.

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.